Table 5 |
|||||||
|
Predicted mean ratios of ANOVA analyses of CM prognostic biomarkers |
|||||||
|
CATEGORY |
|||||||
|
|
|||||||
|
BIOMARKER RATIO |
OVERALL P-VALUE |
HC vs. MM |
HC vs. CMS |
HC vs. CMNS |
MM vs. CMS |
MM vs. CMNS |
CMS vs. CMNS |
|
|
|||||||
|
IL10:TNFa |
0.3096 |
||||||
|
IP10:VEGF |
<0.0001 |
NS |
NS |
<0.0001 |
NS |
<0.0001 |
<0.0001 |
|
IP10:PDGFbb |
0.0001 |
NS |
NS |
<0.0001 |
NS |
<0.0001 |
0.001 |
|
STNFR2:VEGF |
<0.0001 |
NS |
NS |
<0.0001 |
NS |
<0.0001 |
<0.0001 |
|
STNFR2:PDGFbb |
<0.0001 |
NS |
NS |
<0.0001 |
NS |
<0.0001 |
<0.0001 |
|
sFas:VEGF |
<0.0001 |
NS |
NS |
<0.0001 |
NS |
<0.0001 |
<0.0001 |
|
sFas:PDGFbb |
<0.0001 |
NS |
NS |
<0.0001 |
NS |
<0.0001 |
<0.0001 |
|
|
|||||||
|
Statistical comparison of predicted mean ratios of anti-inflammatory, angiostatic and apoptotic factors versus pro-inflammatory and angiogenic factors in different subject groups. P < 0.05 considered statistically significant; NS, not statistically significant. |
|||||||
|
Jain et al. Malaria Journal 2008 7:83 doi:10.1186/1475-2875-7-83 |
|||||||